Senior Medical Director, Clinical Development
Verastem Inc - Boston, Massachusetts
Posted Oct 28, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Medical Director, Clinical Development Boston, Massachusetts Company Profile: At Verastem Oncology, we address urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We've launched this novel/novel combination therapy in the U.S. and are exploring pathways for Europe and Japan. We continue to advance our pipeline of drugs to help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. This is an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients. Summary We are seeking a Medical Director /Senior Medical Director (level dependent on qualifications) to provide medical and scientific leadership for late-phase solid tumor clinical development, with a focus on the VS-7375 KRAS G12D ON/OFF inhibitor program. This individual will lead the medical aspects of assigned Phase 3 pivotal trial ( s ) , oversee medical monitoring, and contribute directly to regulatory filing and marketing authorization activities. The role requires demonstrated experience conducting late-phase oncology trials and preparing clinical content for regulatory submissions within a cross-functional, matrixed team. Responsibilities Lead the design and medical execution of assigned late-phase solid tumor trials in collaboration with Clinical Science, Clinical Operations, Biostatistics, Regulatory Affairs, and other study team members. Partner with Clinical Operations to establish study plans, timelines, resource needs, and
Read the full description at verastem.bamboohr.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Medical Director
Verastem Inc - Boston, Massachusetts
Senior Medical Director, Early-Stage Clinical Development
Revolution Medicines - Redwood City, California, United States
Senior Medical Director
Keros Therapeutics Inc - Lexington, MA (Hybrid)
Senior / Executive Medical Director, Clinical Development (Oncology)
Iambic Therapeutics - San Diego HQ, San Diego, California, United States